Xtant Medical Holdings, Inc. (XTNT): R&D Expense
$2.10M
Year ended 2025-12-31
$2.22M
Trailing 12 months to 2026-06-30
+31.9%
3-year compound annual growth
+26.2%
5-year compound annual growth
-1.9%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.10M | -11.9% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $2.38M | +78.5% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $1.34M | +46.0% | 2025-03-06, From 2023-01-01 |
| 2022-12-31 | $915.0K | +5.2% | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | $870.0K | +32.4% | 2023-03-07, From 2021-01-01 |
| 2020-12-31 | $657.0K | -29.5% | 2022-03-08, From 2020-01-01 |
| 2019-12-31 | $932.0K | -45.2% | 2021-02-24, From 2019-01-01 |
| 2018-12-31 | $1.70M | -30.3% | 2020-03-05, From 2018-01-01 |
| 2017-12-31 | $2.44M | -28.4% | 2019-04-01, From 2017-01-01 |
| 2016-12-31 | $3.41M | +33.9% | 2018-04-05, From 2016-01-01 |
| 2015-12-31 | $2.55M | +76.5% | 2017-03-29, From 2015-01-01 |
| 2014-12-31 | $1.44M | +152.1% | 2016-03-24, From 2014-01-01 |
| 2013-12-31 | $572.4K | n/a | 2015-03-18, From 2013-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | 2025-12-31 | $2.10M | -11.9% |
| Neuronetics, Inc. (STIM) | 2025-12-31 | $6.58M | -48.4% |
| Orasure Technologies Inc (OSUR) | 2025-12-31 | $42.53M | +63.3% |
| Anika Therapeutics, Inc. (ANIK) | 2025-12-31 | $25.77M | +0.9% |
| Heartflow, Inc. (HTFL) | 2025-12-31 | $64.92M | +49.2% |
| Beta Bionics, Inc. (BBNX) | 2025-12-31 | $34.79M | +32.9% |
| NeuroPace Inc (NPCE) | 2025-12-31 | $27.89M | +17.9% |
| Kestra Medical Technologies, Ltd. (KMTS) | 2026-04-30 | $19.48M | +24.5% |
| Pulmonx Corp (LUNG) | 2025-12-31 | $19.49M | +10.9% |
Compare XTNT, STIM, OSUR, ANIK side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗